SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

🔥 COCK Token – The Ultimate Cross-Chain MemeFi Powerhouse 🔥  In just under 20 days, $COCK has smashed expectations, broken ATHs, and built a project that’s shaking up Cardano and the entire crypto space. 🐓 What Makes $COCK Special?      The Name: Love it or hate it, the energy and engagement it generates are undeniable. The nuance in language and wild appeal set us apart.     #MEMEFI Pioneer: We’re not just another meme coin. $COCK is leading a movement by combining DeFi mechanics, game theory, and community engagement into a groundbreaking ecosystem.     COCKARENA: At the core of our ecosystem is the COCKARENA, a PvP HODL game. Players battle it out, and early exit fees fuel redistributions, burns, and the treasury. This ensures price appreciation and long-term sustainability for loyal holders.  🎰 The COCK Casino  Our casino isn’t just fun—it’s a serious revenue stream for the FLOCK.      Games: Bonanza, Crash, Blackjack, and Roulette (coming soon!).     Impact: Over 7,834 ADA in profits generated within days, directly supporting rewards, burns, and reinvestment.  💰 COCK-ARENA Loans  Unlock liquidity without selling your tokens.      Loan Terms: Borrow up to 30% of your holdings while continuing to earn rewards in the arena.     Investor Focus: Perfect for savvy investors staying in the game while tapping into their holdings.  🤝 Our Insane Partnerships  We’re bridging gaps, building alliances, and breaking barriers across the crypto space. Key Partners:      DANZO: Powering #MEMEFI with Arena, Casino, and Loans.     KLENEK: Interactive training room.     HSKN (Charles Hoskilien): Supporting and starting COCKPIN with 115 AIR NODES for DePIN aggregation. Plans to add APEX and Earth Nodes through a crypto company incorporated in Costa Rica.     ELITE CATS / SNEKKIES / HOT / BANK: Rewarding NFT holders with COCK-LOCK tokens and vice versa.     OCKZ: COCKSOCKS, Golden Cock Ticket (1M COCK), airdrop rewards, and whitelist perks for holders of 200 ADA worth of $COCK.     OLI Partnership:         Content Creation: Lux and the team are crafting engaging educational content about memes and MemeFi for OLi's platform.         Strategic Investment: The OLi Community Trust will invest in $COCK, distributing 100% of rewards to $OLI holders.         Community Reach: Over 22,000 learners will discover $COCK through OLi's gamified ecosystem.     Hi-Rez the Rapper: Expanding reach in marketing and entertainment.     KUNO, CALEB, CADEN, FITY, ROVER, WhaleInsider: Influential collaborators driving crypto adoption and growth.     Cardano Girls: Helping us understand and communicate effectively with ADA’s female audience.     WallStreetBets: Breaking barriers and increasing engagement.     Antonio Brown: Endorsing, supporting, and even playing in the casino and arena!     Advisors:         BERIS, HECKTHESNEK, RTB, CRYPTOGENIUS: Trusted names advising and supporting the project.  Future Partnerships:  More collaborations are in the pipeline to continue expanding engagement and bring new eyes to ADA and CNTs. 🔥 Unmatched Results in Just 20 Days      Supply Burned: 1.65%, worth 148K ADA!     Arena Fees Collected: 54M COCK, worth over 500K ADA, fueling rewards, burns, and partnerships.     Staked COCK-LOCK: 11M COCK-LOCK in the liquid staking platform, with more coming.     Casino Revenue: Skyrocketing profits directly rewarding holders and growing the treasury.     Top Blast Contests: Generated over 120K ADA in volume, rewarding participants with over 50K ADA in prizes.  🌍 Our Vision  To be the most decentralized, rewarding, and innovative token on Cardano while fostering cross-chain collaboration and onboarding the masses.      Breaking Barriers: We’re bringing BTC, ETH, SOL, and other chains into the fold.     Community-Driven: Focused on building bridges and showcasing that crypto can be fun, rewarding, and sustainable.     Expansion: This is just the beginning. With more burns, rewards, and partnerships on the way, $COCK is set to redefine what’s possible in the MemeFi space.  💎 Time in the arena &gt; Timing the market. The FLOCK is unstoppable. Let’s keep breaking walls for Cardano and onboard new users as we take $COCK to new heights.

CockCardano

The Cardano-based meme token CockCardano is generating significant buzz as its community leverages real-world business integration through their "Cocky Wings" food venture to fuel token buybacks. Supporters are actively rallying around the project's unique brand identity and ongoing ecosystem expansion, maintaining high engagement across social channels.

T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.

T-Mobile US Inc

T-Mobile US is attracting significant market attention as traders closely monitor technical indicators and institutional sentiment ahead of upcoming earnings. While some investors are highlighting the stock's potential for a technical bounce from oversold levels, others are actively debating the impact of sector-wide competition and broader macro pressures on the company's growth trajectory.

ShapeShift is a decentralized, multichain cryptocurrency platform that empowers users to swap, track, buy, and earn with over 30,000 assets across the top blockchains such as Bitcoin, Ethereum, Dogecoin, Cosmos, and more. The platform emphasizes financial sovereignty and self-custody, providing an open-source environment where users can engage with the most popular crypto tools and services to trade, earn, and hodl their digital assets. FOX token holders can submit and vote on proposals, helping to shape the future of ShapeShift.

ShapeShift FOX Token

ShapeShift FOX is experiencing heightened community interest driven by its low market cap and potential as a decentralized finance contender comparable to major platforms like Uniswap. Investors are actively debating the token's upside potential, with many advocating for long-term holding while others speculate on its ability to break through long-standing technical resistance levels.

Pippin is an SVG unicorn drawn using the latest LLM benchmarks on ChatGPT 4o. It is an autonomous AI agent on X. Pippin was created by Yohei Nakajima, a recognised innovator and thought leader in the Al VC space (followed by Jeff Bezos and Marc Andreessen). He is known for his build-in-public approach and has been at the forefront of the ‘AI for VC’ movement, launching over 100+ AI-driven prototypes, automation agents &amp; open-source projects.  His most notable build is BabyAGI (March 2023), the first popular open-source autonomous agent with task-planning capability. The project went viral on Twitter amassing millions of impressions and resulting in tens of thousands of GitHub stars, dozens of Arxiv citations, coverage across major online media publications globally, and many speaker engagements including the inaugural TED AI in San Francisco.

pippin

PIPPIN is driving intense community debate as traders weigh potential short-squeeze opportunities against heavy warnings regarding high wallet concentration and allegations of market manipulation. While some participants highlight its resilience and momentum as a standout Solana-based AI token, others caution against participating in what they describe as a high-risk asset prone to volatility and insider influence.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta (KTA) is capturing significant community attention as investors debate its potential as a high-throughput blockchain solution for institutional finance, often drawing comparisons to XRP and Solana. While bulls are actively accumulating during current volatility, citing high transaction speeds and institutional backing, skeptics remain wary of the project's long-term utility and recent price depreciation.

Listed Funds Trust - Roundhill Magnificent Seven ETF

Roundhill Magnificent Seven ETF

The Roundhill Magnificent Seven ETF (MAGS) is a central focus for traders acting as a macro barometer, with community discussion currently divided between those looking for dip-buying opportunities at key technical support levels and others rotating into defensive sectors like energy and financials. Investors are heavily debating the sustainability of AI capital expenditures versus valuation concerns, as the ETF's price action continues to dictate broader market sentiment amid ongoing rotation away from concentrated mega-cap tech holdings.

ETF Opportunities Trust - T-Rex 2X Long MSTR Daily Target ETF

T-Rex 2X Long MSTR Daily Target ETF

MSTU is seeing heavy retail engagement as traders weigh aggressive accumulation strategies against concerns over potential reverse stock splits and volatility decay common in leveraged crypto-linked ETFs. The community remains deeply divided, with some betting on a rapid short squeeze driven by Michael Saylor's continued Bitcoin acquisitions, while others warn of significant downside risks if the underlying asset fails to sustain key technical support levels.

Welltower, Inc. is a health care infrastructure company, which engages in seniors housing operations, post-acute providers and health systems to fund the real estate infrastructure. The company's operating business segments include Seniors Housing Operating, Triple-Net, and Outpatient Medical. The Seniors Housing Operating segment operates properties including seniors apartments, independent living and independent supportive living, continuing care retirement communities, and assisted living, Alzheimer's dementia care and includes care homes with or without nursing. The Triple-Net segment properties offer services including independent living & supportive living (Canada), assisted living, continuing care retirement communities, Alzheimer's/dementia care and care homes with or without nursing (U.K.), and long-term/post-acute care. The Outpatient Medical segment invests in and operates outpatient medical buildings including physician offices, ambulatory surgery centers, diagnostic facilities, outpatient services and/or labs. The company was founded in 1970 and is headquartered in Toledo, OH.

Welltower Inc.

Welltower is currently drawing significant investor attention due to the recent acquisition of a large active adult portfolio, signaling continued expansion in the seniors housing sector. Community discussion is focused on the REIT's strategic growth, strong operating momentum in its portfolio, and various price target upgrades from analysts despite broader macroeconomic headwinds.

Journey Medical Corp. is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its brands include QBREXZA, Accutane, Targadox, AMZEEQ, Ximino, ZILXI, Exelderm, and Luxamend. The company was founded by Claude Maraoui in October 2014 and is headquartered in Scottsdale, AZ.

Journey Medical Corp

Journey Medical is currently trending as investors monitor the company's path toward profitability following the FDA approval of Emrosi, with the community actively discussing the drug's potential as a new standard of care in the rosacea market. Traders are closely tracking the stock for signs of institutional interest and evaluating management's upcoming commercialization strategy and partnership guidance.

ProShares Trust - ProShares UltraPro Short S&P 500

ProShares UltraPro Short S&P 500 ETF

Investors are actively debating market vulnerability, with many utilizing SPXU as a tactical hedge to capitalize on potential downside risks amidst concerns of overextended valuations and geopolitical uncertainty. Discussion remains highly divided between those betting on an inevitable correction and others cautioning against fighting the prevailing bullish trend, leading to heavy focus on managing volatility through leveraged inverse ETFs.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Zacks Research Upgrades Eton Pharmaceuticals (NASDAQ:ETON) to Strong-Buy

Zacks Research upgraded shares of Eton Pharmaceuticals from a "hold" rating to a "strong-buy" rating in a report on Thursday...

Eton Pharmaceuticals (NASDAQ:ETON) Rating Increased to Buy at Wall Street Zen

Wall Street Zen upgraded shares of Eton Pharmaceuticals from a "hold" rating to a "buy" rating in a report on Saturday...

Eton Pharmaceuticals (NASDAQ:ETON) Stock Price Expected to Rise, HC Wainwright Analyst Says

HC Wainwright increased their target price on Eton Pharmaceuticals from $37.00 to $52.00 and gave the stock a "buy" rating in a report on Friday...

B. Riley Financial Forecasts Strong Price Appreciation for Eton Pharmaceuticals (NASDAQ:ETON) Stock

B. Riley Financial boosted their price target on Eton Pharmaceuticals from $26.00 to $31.00 and gave the company a "buy" rating in a report on Friday...

Craig Hallum Forecasts Strong Price Appreciation for Eton Pharmaceuticals (NASDAQ:ETON) Stock

Craig Hallum boosted their price target on Eton Pharmaceuticals from $30.00 to $35.00 and gave the company a "buy" rating in a research note on Friday...

Eton Pharmaceuticals (NASDAQ:ETON) Sees Large Volume Increase  - Still a Buy?

Eton Pharmaceuticals (NASDAQ:ETON) Sees Large Volume Increase - Here's Why...

Does Eton Pharmaceuticals (ETON) Have the Potential to Rally 49.25% as Wall Street Analysts Expect?

The mean of analysts' price targets for Eton Pharmaceuticals (ETON) points to a 49.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Eton Pharmaceuticals (NASDAQ:ETON) Posts Quarterly Earnings Results, Beats Expectations By $0.07 EPS

Eton Pharmaceuticals (NASDAQ:ETON - Get Free Report) posted its earnings results on Thursday. The company reported $0.19 earnings per share for the quarter, topping analysts' consensus estimates of $0.12 by $0.07. The company had revenue of $21.28 million during the quarter, compared to analyst...

Eton Pharmaceuticals Q4 Earnings Call Highlights

Eton Pharmaceuticals (NASDAQ:ETON) reported fourth quarter 2025 product revenue of $21.3 million, an 83% increase from $11.6 million in the prior-year period, as the company highlighted continued growth in its base business, contributions from recent product relaunches, and the early rollout of its...

Eton Pharmaceuticals, Inc. (ETON) Q4 Earnings Lag Estimates

Eton Pharmaceuticals (ETON) delivered earnings and revenue surprises of -58.33% and +4.22%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

$ETON Q4 &#39;25 Earnings Results &amp; Recap

Eton Pharmaceuticals reported total net revenues of $79.95M for the twelve months ended December 31, 2025, an increase from $39.01M in 2024, resulting in a gross profit of $42.74M.

Stocktwits

Eton Pharmaceuticals Inc

 Q4 '25 Earnings Results & Recap

Eton Pharmaceuticals reported total net revenues of $79.95M for the twelve months ended December 31, 2025, an increase from $39.01M in 2024, resulting in a gross profit of $42.74M.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.

Current Price	$22.32
Prev Close	$20.77
Open	$21.40
Dividend Yield	0.00%
50-Day Moving Average	$16.72
Beta	0.78
Avg. Volume	316,859.16
PE Ratio	-124.83

52-Week High	$23.00
52-Week Low	$11.09
Market Capitalization	$608.99M
EPS (Annual)	-$0.171
Price to Book	23.08
Revenue Per Employee	$1.82M

ETON
Eton Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ETON News

ETONEton Pharmaceuticals Inc